- Home
- APLS vs ESBA Comparison
APLS vs ESBA Comparison
Compare APLS & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- ESBA
- Stock Information
- Founded
- APLS 2009
- ESBA N/A
- Country
- APLS United States
- ESBA United States
- Employees
- APLS N/A
- ESBA N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- ESBA
- Sector
- APLS Health Care
- ESBA
- Exchange
- APLS Nasdaq
- ESBA NYSE
- Market Cap
- APLS 2.2B
- ESBA 2.0B
- IPO Year
- APLS 2017
- ESBA 2013
- Fundamental
- Price
- APLS $18.90
- ESBA $7.15
- Analyst Decision
- APLS Buy
- ESBA
- Analyst Count
- APLS 19
- ESBA 0
- Target Price
- APLS $37.61
- ESBA N/A
- AVG Volume (30 Days)
- APLS 2.1M
- ESBA 2.8K
- Earning Date
- APLS 07-31-2025
- ESBA 01-01-0001
- Dividend Yield
- APLS N/A
- ESBA 1.94%
- EPS Growth
- APLS N/A
- ESBA 3.47
- EPS
- APLS N/A
- ESBA 0.30
- Revenue
- APLS $775,839,000.00
- ESBA $762,039,000.00
- Revenue This Year
- APLS $8.00
- ESBA N/A
- Revenue Next Year
- APLS $13.82
- ESBA N/A
- P/E Ratio
- APLS N/A
- ESBA $25.03
- Revenue Growth
- APLS 48.04
- ESBA 0.78
- 52 Week Low
- APLS $16.10
- ESBA $6.39
- 52 Week High
- APLS $41.94
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- APLS 51.99
- ESBA 35.33
- Support Level
- APLS $19.16
- ESBA $7.14
- Resistance Level
- APLS $20.40
- ESBA $8.19
- Average True Range (ATR)
- APLS 0.93
- ESBA 0.17
- MACD
- APLS -0.04
- ESBA -0.07
- Stochastic Oscillator
- APLS 32.64
- ESBA 8.91
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.